awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q53449720-16B5F714-B539-44E6-880E-57FD67526DF7
Q53449720-16B5F714-B539-44E6-880E-57FD67526DF7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53449720-16B5F714-B539-44E6-880E-57FD67526DF7
The role of the new basal insulin analogs in addressing unmet clinical needs in people with type 1 and type 2 diabetes.
P2860
Q53449720-16B5F714-B539-44E6-880E-57FD67526DF7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53449720-16B5F714-B539-44E6-880E-57FD67526DF7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d8bd610f18ac2ada8c237dff85e4ebdc0fa3c6be
P2860
New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 1 Diabetes: A Randomized, Phase 3a, Open-Label Clinical Trial (EDITION 4).